We are live on ! Find out more
QIM

Quantitative Investment Management Portfolio holdings

AUM $963M
1-Year Est. Return 12.95%
This Fund
S&P 500
This Quarter Est. Return
-13.36%
1 Year Est. Return
+12.95%
3 Year Est. Return
+35.29%
5 Year Est. Return
+26.17%
10 Year Est. Return
+187.22%
AUM
$1.33B
AUM Growth
+$665M
Cap. Flow
+$841M
Cap. Flow %
63.29%
Top 10 Hldgs %
16.01%
Holding
883
New
455
Increased
158
Reduced
51
Closed
219

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.07%
2 Healthcare 11.56%
3 Energy 11.43%
4 Technology 8.71%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCC
476
DELISTED
Microsemi Corp
MSCC
$420K 0.03%
+12,800
New +$416K
INGR icon
477
Ingredion
INGR
$6.6B
$419K 0.03%
+4,800
New +$411K
CRR
478
DELISTED
Carbo Ceramics Inc.
CRR
$417K 0.03%
+22,000
New +$640K
AGCO icon
479
AGCO
AGCO
$7.51B
$415K 0.03%
8,900
-10,000
-53% -$512K
PRLB icon
480
Protolabs
PRLB
$2.11B
$415K 0.03%
+6,200
New +$442K
TRP icon
481
TC Energy
TRP
$68.1B
$410K 0.03%
+13,000
New +$467K
HPY
482
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
$409K 0.03%
+6,500
New +$387K
HII icon
483
Huntington Ingalls Industries
HII
$12.7B
$407K 0.03%
3,800
-2,100
-36% -$239K
TFC icon
484
Truist Financial
TFC
$64.3B
$405K 0.03%
11,400
-57,400
-83% -$2.21M
ESPR
485
DELISTED
Esperion Therapeutics
ESPR
$403K 0.03%
+17,100
New +$1.07M
TGT icon
486
Target
TGT
$67.3B
$401K 0.03%
5,100
-93,700
-95% -$7.48M
VNDA icon
487
Vanda Pharmaceuticals
VNDA
$321M
$399K 0.03%
35,400
+13,600
+62% +$166K
WUBA
488
DELISTED
58.com Inc
WUBA
$399K 0.03%
8,500
-21,900
-72% -$1.14M
IMPV
489
DELISTED
Imperva, Inc.
IMPV
$399K 0.03%
+6,100
New +$405K
BOBE
490
DELISTED
Bob Evans Farms, Inc.
BOBE
$398K 0.03%
+9,200
New +$435K
PTR
491
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$397K 0.03%
+5,700
New +$508K
ING icon
492
ING
ING
$101B
$395K 0.03%
+28,000
New +$441K
KITE
493
DELISTED
Kite Pharma, Inc.
KITE
$395K 0.03%
+7,100
New +$447K
AGNC icon
494
AGNC Investment
AGNC
$12.6B
$394K 0.03%
+21,100
New +$405K
AXON
495
Axon Enterprise
AXON
$48.9B
$392K 0.03%
17,800
+4,200
+31% +$111K
ARR
496
Armour Residential REIT
ARR
$2.33B
$390K 0.03%
3,900
+2,917
+297% +$316K
CIVI
497
DELISTED
Civitas Resources
CIVI
$389K 0.03%
+859
New +$799K
GREK
498
Global X MSCI Greece ETF
GREK
$320M
$387K 0.03%
+13,433
New +$398K
GGB icon
499
Gerdau
GGB
$10B
$384K 0.03%
+353,556
New +$484K
MEOH icon
500
Methanex
MEOH
$4.14B
$384K 0.03%
+11,600
New +$497K

Similar funds

Quantitative Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Quantitative Investment Management held 883 positions worth $1.33B, up 100% from $664M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Quantitative Investment Management deployed $841M of net new capital in Q3 2015, opening 455 new positions and adding to 158 existing holdings. Its largest new stake was iShares Biotechnology ETF: 384,900 shares worth $38.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 8.3% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $54M trimmed.

  • Quantitative Investment Management's largest Q3 2015 buy was iShares Biotechnology ETF: 384,900 shares worth $38.9M.
  • Quantitative Investment Management added most to iShares MSCI Brazil ETF in Q3 2015, an estimated $22.5M increase.
  • Quantitative Investment Management's biggest Q3 2015 reduction was Meta Platforms (Facebook), cutting an estimated $54M.
  • Quantitative Investment Management fully exited Gilead Sciences in Q3 2015, selling an estimated $30.3M.
  • Quantitative Investment Management's ten largest holdings make up 16% of its $1.33B portfolio in Q3 2015.
  • Quantitative Investment Management opened 455 new positions and closed 219 in Q3 2015.
  • Quantitative Investment Management's portfolio value rose 100% quarter-over-quarter to $1.33B.

Based on Quantitative Investment Management's 13F filing for Q3 2015, filed 10 Nov 2015.